[Management of drug-induced agranulocytosis associated with severe septicemia].
D000328:Adult; D000368:Aged; D000380:Agranulocytosis / Q000097:blood / Q000139:chemically induced*; D002701:Chloramphenicol / Q000009:adverse effects; D005260:Female; D006801:Humans; D017708:Leukocyte Transfusion; D008094:Lithium / Q000627:therapeutic use; D016651:Lithium Carbonate; D008297:Male; D008875:Middle Aged; D011720:Pyrazoles / Q000009:adverse effects; D047069:Pyrazolones; D018805:Sepsis / Q000139:chemically induced* / Q000188:drug therapy; D013449:Sulfonamides / Q000009:adverse effects
D011720:Pyrazoles; D047069:Pyrazolones; D013449:Sulfonamides; D016651:Lithium Carbonate; C038362:pyrazolone; D002701:Chloramphenicol; D008094:Lithium
Adatok a súlyos, septicaemiával járó gyógyszer okozta agranulocytosis kezeléséhez.